EP1904088A4 - Compositions et methodes de traitement du cancer - Google Patents

Compositions et methodes de traitement du cancer

Info

Publication number: EP1904088A4
Authority: EP; European Patent Office
Prior art keywords: cancer; compositions; treatment; methods
Prior art date: 2005-05-24
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Withdrawn

Application number

EP06784482A

Other languages

German (de)

English (en)

Other versions

EP1904088A2 (fr

Inventor

Andrea Alan D D

Toshiyasu Taniguchi

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Dana Farber Cancer Institute Inc

Original Assignee

Dana Farber Cancer Institute Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2005-05-24

Filing date

2006-05-24

Publication date

2010-03-31

2006-05-24 Application filed by Dana Farber Cancer Institute Inc filed Critical Dana Farber Cancer Institute Inc

2008-04-02 Publication of EP1904088A2 publication Critical patent/EP1904088A2/fr

2010-03-31 Publication of EP1904088A4 publication Critical patent/EP1904088A4/fr

Status Withdrawn legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
- G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
- G01N2333/4701—Details
- G01N2333/4703—Regulators; Modulating activity
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
- G01N2500/10—Screening for compounds of potential therapeutic value involving cells
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Engineering & Computer Science (AREA)
Immunology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Epidemiology (AREA)
Hematology (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Molecular Biology (AREA)
Oncology (AREA)
Biomedical Technology (AREA)
Urology & Nephrology (AREA)
Hospice & Palliative Care (AREA)
Biochemistry (AREA)
Cell Biology (AREA)
Biotechnology (AREA)
Food Science & Technology (AREA)
Physics & Mathematics (AREA)
Analytical Chemistry (AREA)
Microbiology (AREA)
General Physics & Mathematics (AREA)
Pathology (AREA)
Bioinformatics & Cheminformatics (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Investigating Or Analysing Biological Materials (AREA)
Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

EP06784482A 2005-05-24 2006-05-24 Compositions et methodes de traitement du cancer Withdrawn EP1904088A4 (fr)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US68413605P	2005-05-24	2005-05-24
PCT/US2006/020390 WO2006127978A2 (fr)	2005-05-24	2006-05-24	Compositions et methodes de traitement du cancer

Publications (2)

Publication Number	Publication Date
EP1904088A2 EP1904088A2 (fr)	2008-04-02
EP1904088A4 true EP1904088A4 (fr)	2010-03-31

Family

ID=37452873

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EP06784482A Withdrawn EP1904088A4 (fr)	2005-05-24	2006-05-24	Compositions et methodes de traitement du cancer

Country Status (5)

Country	Link
EP (1)	EP1904088A4 (fr)
JP (1)	JP2008545965A (fr)
AU (1)	AU2006249807A1 (fr)
CA (1)	CA2609751A1 (fr)
WO (1)	WO2006127978A2 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU2007325900A1 (en)	2006-10-20	2008-06-05	Dnar, Inc.	DNA damage repair inhibitors and methods for treating cancer
CA2680549A1 (fr) *	2007-03-12	2008-09-18	Alan D. D'andrea	Pronostic, diagnostic et utilisations dans le traitement du cancer de fanci et des agents de modulation de fanci
WO2012009475A1 (fr) *	2010-07-14	2012-01-19	Oregon Health & Science University	Méthodes de traitement du cancer par inhibition de la déméthylase 1 spécifique de la lysine
WO2015077753A1 (fr) *	2013-11-25	2015-05-28	The University Of Toledo	Inhibiteurs de ercc1-xpf et leurs méthodes d'utilisation
JP6768702B2 (ja) *	2015-04-22	2020-10-14	シン−ナットプロダクツエンタープライズエルエルシー	共結晶組成物及びその医薬用途
KR20230066647A (ko)	2016-06-17	2023-05-16	마젠타 테라퓨틱스 인코포레이티드	Cd117+ 세포의 고갈을 위한 조성물 및 방법

Citations (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2005081783A2 (fr) *	2004-01-30	2005-09-09	Dana Farber Cancer Institute	Procedes pour determiner et quantifier l'exposition a des rayonnements ou a des genotoxines

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20030188326A1 (en) *	2000-11-03	2003-10-02	Dana Farber Cancer Institute	Methods and compositions for the diagnosis of cancer susceptibilities and defective DNA repair mechanisms and treatment thereof
EP1349924A2 (fr) *	2000-11-03	2003-10-08	Dana Farber Cancer Institute	Procedes et compositions pour le diagnostic des sensibilites aux cancers et mecanismes de reparation d'adn defectueux et traitement correspondant

2006
- 2006-05-24 JP JP2008513749A patent/JP2008545965A/ja not_active Withdrawn
- 2006-05-24 CA CA002609751A patent/CA2609751A1/fr not_active Abandoned
- 2006-05-24 EP EP06784482A patent/EP1904088A4/fr not_active Withdrawn
- 2006-05-24 WO PCT/US2006/020390 patent/WO2006127978A2/fr active Application Filing
- 2006-05-24 AU AU2006249807A patent/AU2006249807A1/en not_active Abandoned

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2005081783A2 (fr) *	2004-01-30	2005-09-09	Dana Farber Cancer Institute	Procedes pour determiner et quantifier l'exposition a des rayonnements ou a des genotoxines

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
BAGBY GROVER C ET AL: "Cisplatin and the sensitive cell.", NATURE MEDICINE MAY 2003, vol. 9, no. 5, May 2003 (2003-05-01), pages 513 - 514, XP002550337, ISSN: 1078-8956 *
CHIRNOMAS DEBORAH ET AL: "Chemosensitization to cisplatin by inhibitors of the Fanconi anemia/BRCA pathway", MOLECULAR CANCER THERAPEUTICS, vol. 5, no. 4, April 2006 (2006-04-01), pages 952 - 961, XP002550338, ISSN: 1535-7163 *

Also Published As

Publication number	Publication date
JP2008545965A (ja)	2008-12-18
WO2006127978A2 (fr)	2006-11-30
CA2609751A1 (fr)	2006-11-30
WO2006127978A3 (fr)	2009-04-30
EP1904088A2 (fr)	2008-04-02
AU2006249807A1 (en)	2006-11-30

Publication	Publication Date	Title
EP2125855A4 (fr)	2013-03-27	Procédés et compositions pour le traitement du cancer ou d'autres maladies
IL188746A0 (en)	2008-08-07	Treatment of cancer
ZA200904492B (en)	2022-03-30	Compositions and methods for the treatment of infections and tumors
PL1765391T3 (pl)	2013-08-30	Kompozycje bakteryjne do leczenia nowotworów
EP1928453A4 (fr)	2012-11-28	Procedes et compositions permettant de prevenir et de traiter les maladies renales
EP2049151A4 (fr)	2010-03-24	Méthodes et compositions pour le traitement du cancer
WO2007081751A9 (fr)	2016-08-25	Compositions et procedes destines au traitement du cancer
IL188430A0 (en)	2008-11-03	Treatment of tumors
ZA200708575B (en)	2014-03-26	Methods and compositions for treating or preventing cancer
IL176919A0 (en)	2006-12-10	Methods and compositions for treating cancer
IL196843A0 (en)	2009-11-18	Compositions and methods for the treatment of radiation proctosigmoitis
ZA200800452B (en)	2015-03-25	Methods and compositions for the prevention and treatment of kidney disease
EP1855662A4 (fr)	2009-12-23	Methodes et compositions destinees a traiter le cancer
HK1117780A1 (en)	2009-01-23	Compounds and methods for the treatment of cancer
ZA200708819B (en)	2014-12-23	Methods and compositions for the prevention and treatment of kidney disease
AU2006251167A8 (en)	2008-04-03	Tetrahydropyridothiophenes for use in the treatment of cancer
AU2006251169A8 (en)	2008-04-03	Tetrahydropyridothiophenes for use in the treatment of cancer
IL187405A0 (en)	2011-07-31	Methods and compositions for the treatment of pain
EP2150270A4 (fr)	2011-09-28	Méthodes et compositions pour traiter le cancer
EP1812596A4 (fr)	2010-07-14	Traitement du cancer et compositions
EP1904088A4 (fr)	2010-03-31	Compositions et methodes de traitement du cancer
IL187792A0 (en)	2008-11-03	4-anilino-3-quinolinecarbonitriles for the treatment of cancer
IL226363A0 (en)	2013-06-27	Compounds and methods for treating cancer
GB0517387D0 (en)	2005-10-05	Combinations for the treatment of cancer
ZA200805522B (en)	2009-04-29	Dioxoiane dérivates for the treatment of cancer

Legal Events

Date	Code	Title	Description
2008-02-29	PUAI	Public reference made under article 153(3) epc to a published international application that has entered the european phase	Free format text: ORIGINAL CODE: 0009012
2008-04-02	17P	Request for examination filed	Effective date: 20071221
2008-04-02	AK	Designated contracting states	Kind code of ref document: A2 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR
2008-04-02	AX	Request for extension of the european patent	Extension state: AL BA HR MK YU
2008-08-27	DAX	Request for extension of the european patent (deleted)
2009-06-03	R17D	Deferred search report published (corrected)	Effective date: 20090430
2009-06-10	RAP1	Party data changed (applicant data changed or rights of an application transferred)	Owner name: DANA FARBER CANCER INSTITUTE, INC.
2009-06-10	RIC1	Information provided on ipc code assigned before grant	Ipc: C07K 16/00 20060101ALI20090504BHEP Ipc: A61K 38/00 20060101ALI20090504BHEP Ipc: G01N 33/53 20060101AFI20090504BHEP
2010-03-31	A4	Supplementary search report drawn up and despatched	Effective date: 20100301
2010-07-21	17Q	First examination report despatched	Effective date: 20100616
2011-11-16	RAP1	Party data changed (applicant data changed or rights of an application transferred)	Owner name: DANA-FARBER CANCER INSTITUTE, INC.
2013-04-26	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN
2013-05-29	18D	Application deemed to be withdrawn	Effective date: 20121201